Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs

Takashi Kohno, Ryutaro Kakinuma, Motoki Iwasaki, Taiki Yamaji, Hideo Kunitoh, Kenji Suzuki, Yoko Shimada, Kouya Shiraishi, Yoshio Kasuga, Gerson Shigeaki Hamada, Koh Furuta, Koji Tsuta, Hiromi Sakamoto, Aya Kuchiba, Seiichiro Yamamoto, Yae Kanai, Shoichiro Tsugane, Jun Yokota

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Estrogen has been indicated to play an etiological role in the development of lung adenocarcinoma (ADC), particularly bronchioloalveolar carcinoma (BAC), a type of ADC that develops from a benign adenomatous lesion, atypical adenomatous hyperplasia (AAH). Polymorphisms in the CYP19A1 gene cause interindividual differences in estrogen levels. Here, 13 CYP19A1 singlenucleotide polymorphisms (SNPs) were examined for associations with lung AAH risk. AAH is detected as ground-glass opacity (GGO) by computed tomography (CT) examination, and this study consisted of 100 individuals diagnosed with GGO in their lungs among 3088 CT-based cancer screening examinees and 424 without. Minor allele carriers for the rs3764221 SNP showed an elevated risk for GGO [odds ratio (OR) = 1.72, P = 0.017]. Associations of this SNP with risks for lung AAH and BAC in the lungs were next examined using 359 ADC cases whose resected lung lobes were subjected to a histological examination for AAH accompaniment and the presence of BAC components and 330 controls without cancer. The ORs were also increased for lung ADC accompanied by AAH (OR = 1.74, P = 0.029) as well as lung ADC with BAC components (OR = 1.41, P = 0.091). The minor allele was associated with an increased circulating estradiol level (P = 0.079) in a population of 363 postmenopausal women without cancer. These results indicate that CYP19A1 polymorphisms are involved in the risk for lung AAH and BAC in the lungs by causing differences in estrogen levels.

Original languageEnglish
Pages (from-to)1794-1799
Number of pages6
JournalCarcinogenesis
Volume31
Issue number10
DOIs
Publication statusPublished - 2010 Aug 5
Externally publishedYes

Fingerprint

Bronchiolo-Alveolar Adenocarcinoma
Hyperplasia
Lung
Glass
Estrogens
Odds Ratio
Adenocarcinoma
Alleles
Tomography
Early Detection of Cancer
Estradiol
Neoplasms

ASJC Scopus subject areas

  • Cancer Research

Cite this

Kohno, T., Kakinuma, R., Iwasaki, M., Yamaji, T., Kunitoh, H., Suzuki, K., ... Yokota, J. (2010). Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs. Carcinogenesis, 31(10), 1794-1799. https://doi.org/10.1093/carcin/bgq159

Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs. / Kohno, Takashi; Kakinuma, Ryutaro; Iwasaki, Motoki; Yamaji, Taiki; Kunitoh, Hideo; Suzuki, Kenji; Shimada, Yoko; Shiraishi, Kouya; Kasuga, Yoshio; Hamada, Gerson Shigeaki; Furuta, Koh; Tsuta, Koji; Sakamoto, Hiromi; Kuchiba, Aya; Yamamoto, Seiichiro; Kanai, Yae; Tsugane, Shoichiro; Yokota, Jun.

In: Carcinogenesis, Vol. 31, No. 10, 05.08.2010, p. 1794-1799.

Research output: Contribution to journalArticle

Kohno, T, Kakinuma, R, Iwasaki, M, Yamaji, T, Kunitoh, H, Suzuki, K, Shimada, Y, Shiraishi, K, Kasuga, Y, Hamada, GS, Furuta, K, Tsuta, K, Sakamoto, H, Kuchiba, A, Yamamoto, S, Kanai, Y, Tsugane, S & Yokota, J 2010, 'Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs', Carcinogenesis, vol. 31, no. 10, pp. 1794-1799. https://doi.org/10.1093/carcin/bgq159
Kohno, Takashi ; Kakinuma, Ryutaro ; Iwasaki, Motoki ; Yamaji, Taiki ; Kunitoh, Hideo ; Suzuki, Kenji ; Shimada, Yoko ; Shiraishi, Kouya ; Kasuga, Yoshio ; Hamada, Gerson Shigeaki ; Furuta, Koh ; Tsuta, Koji ; Sakamoto, Hiromi ; Kuchiba, Aya ; Yamamoto, Seiichiro ; Kanai, Yae ; Tsugane, Shoichiro ; Yokota, Jun. / Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs. In: Carcinogenesis. 2010 ; Vol. 31, No. 10. pp. 1794-1799.
@article{fa4ddf38e57f43589fbea22b6e773fbf,
title = "Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs",
abstract = "Estrogen has been indicated to play an etiological role in the development of lung adenocarcinoma (ADC), particularly bronchioloalveolar carcinoma (BAC), a type of ADC that develops from a benign adenomatous lesion, atypical adenomatous hyperplasia (AAH). Polymorphisms in the CYP19A1 gene cause interindividual differences in estrogen levels. Here, 13 CYP19A1 singlenucleotide polymorphisms (SNPs) were examined for associations with lung AAH risk. AAH is detected as ground-glass opacity (GGO) by computed tomography (CT) examination, and this study consisted of 100 individuals diagnosed with GGO in their lungs among 3088 CT-based cancer screening examinees and 424 without. Minor allele carriers for the rs3764221 SNP showed an elevated risk for GGO [odds ratio (OR) = 1.72, P = 0.017]. Associations of this SNP with risks for lung AAH and BAC in the lungs were next examined using 359 ADC cases whose resected lung lobes were subjected to a histological examination for AAH accompaniment and the presence of BAC components and 330 controls without cancer. The ORs were also increased for lung ADC accompanied by AAH (OR = 1.74, P = 0.029) as well as lung ADC with BAC components (OR = 1.41, P = 0.091). The minor allele was associated with an increased circulating estradiol level (P = 0.079) in a population of 363 postmenopausal women without cancer. These results indicate that CYP19A1 polymorphisms are involved in the risk for lung AAH and BAC in the lungs by causing differences in estrogen levels.",
author = "Takashi Kohno and Ryutaro Kakinuma and Motoki Iwasaki and Taiki Yamaji and Hideo Kunitoh and Kenji Suzuki and Yoko Shimada and Kouya Shiraishi and Yoshio Kasuga and Hamada, {Gerson Shigeaki} and Koh Furuta and Koji Tsuta and Hiromi Sakamoto and Aya Kuchiba and Seiichiro Yamamoto and Yae Kanai and Shoichiro Tsugane and Jun Yokota",
year = "2010",
month = "8",
day = "5",
doi = "10.1093/carcin/bgq159",
language = "English",
volume = "31",
pages = "1794--1799",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs

AU - Kohno, Takashi

AU - Kakinuma, Ryutaro

AU - Iwasaki, Motoki

AU - Yamaji, Taiki

AU - Kunitoh, Hideo

AU - Suzuki, Kenji

AU - Shimada, Yoko

AU - Shiraishi, Kouya

AU - Kasuga, Yoshio

AU - Hamada, Gerson Shigeaki

AU - Furuta, Koh

AU - Tsuta, Koji

AU - Sakamoto, Hiromi

AU - Kuchiba, Aya

AU - Yamamoto, Seiichiro

AU - Kanai, Yae

AU - Tsugane, Shoichiro

AU - Yokota, Jun

PY - 2010/8/5

Y1 - 2010/8/5

N2 - Estrogen has been indicated to play an etiological role in the development of lung adenocarcinoma (ADC), particularly bronchioloalveolar carcinoma (BAC), a type of ADC that develops from a benign adenomatous lesion, atypical adenomatous hyperplasia (AAH). Polymorphisms in the CYP19A1 gene cause interindividual differences in estrogen levels. Here, 13 CYP19A1 singlenucleotide polymorphisms (SNPs) were examined for associations with lung AAH risk. AAH is detected as ground-glass opacity (GGO) by computed tomography (CT) examination, and this study consisted of 100 individuals diagnosed with GGO in their lungs among 3088 CT-based cancer screening examinees and 424 without. Minor allele carriers for the rs3764221 SNP showed an elevated risk for GGO [odds ratio (OR) = 1.72, P = 0.017]. Associations of this SNP with risks for lung AAH and BAC in the lungs were next examined using 359 ADC cases whose resected lung lobes were subjected to a histological examination for AAH accompaniment and the presence of BAC components and 330 controls without cancer. The ORs were also increased for lung ADC accompanied by AAH (OR = 1.74, P = 0.029) as well as lung ADC with BAC components (OR = 1.41, P = 0.091). The minor allele was associated with an increased circulating estradiol level (P = 0.079) in a population of 363 postmenopausal women without cancer. These results indicate that CYP19A1 polymorphisms are involved in the risk for lung AAH and BAC in the lungs by causing differences in estrogen levels.

AB - Estrogen has been indicated to play an etiological role in the development of lung adenocarcinoma (ADC), particularly bronchioloalveolar carcinoma (BAC), a type of ADC that develops from a benign adenomatous lesion, atypical adenomatous hyperplasia (AAH). Polymorphisms in the CYP19A1 gene cause interindividual differences in estrogen levels. Here, 13 CYP19A1 singlenucleotide polymorphisms (SNPs) were examined for associations with lung AAH risk. AAH is detected as ground-glass opacity (GGO) by computed tomography (CT) examination, and this study consisted of 100 individuals diagnosed with GGO in their lungs among 3088 CT-based cancer screening examinees and 424 without. Minor allele carriers for the rs3764221 SNP showed an elevated risk for GGO [odds ratio (OR) = 1.72, P = 0.017]. Associations of this SNP with risks for lung AAH and BAC in the lungs were next examined using 359 ADC cases whose resected lung lobes were subjected to a histological examination for AAH accompaniment and the presence of BAC components and 330 controls without cancer. The ORs were also increased for lung ADC accompanied by AAH (OR = 1.74, P = 0.029) as well as lung ADC with BAC components (OR = 1.41, P = 0.091). The minor allele was associated with an increased circulating estradiol level (P = 0.079) in a population of 363 postmenopausal women without cancer. These results indicate that CYP19A1 polymorphisms are involved in the risk for lung AAH and BAC in the lungs by causing differences in estrogen levels.

UR - http://www.scopus.com/inward/record.url?scp=77957813234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957813234&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgq159

DO - 10.1093/carcin/bgq159

M3 - Article

C2 - 20688833

AN - SCOPUS:77957813234

VL - 31

SP - 1794

EP - 1799

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 10

ER -